Why Psychiatry Needs Psychedelics and Psychedelics Need Psychiatry

被引:12
|
作者
Sessa, Ben [1 ]
机构
[1] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales
关键词
hippie culture; LSD; MDMA; psychedelics; psychiatry; MDMA; BABY;
D O I
10.1080/02791072.2014.877322
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Without researching psychedelic drugs for medical therapy, psychiatry is turning its back on a group of compounds that could have great potential. Without the validation of the medical profession, the psychedelic drugs, and those who take them off-license, remain archaic sentiments of the past, with the users maligned as recreational drug abusers and subject to continued negative opinion. These two disparate groups-psychiatrists and recreational psychedelic drug users-are united by their shared recognition of the healing potential of these compounds. A resolution of this conflict is essential for the future of psychiatric medicine and psychedelic culture alike. Progression will come from professionals working in the field adapting to fit a conservative paradigm. In this way, they can provide the public with important treatments and also raise the profile of expanded consciousness in mainstream society.
引用
收藏
页码:57 / 62
页数:6
相关论文
共 50 条
  • [21] Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
    Inserra, Antonio
    De Gregorio, Danilo
    Gobbi, Gabriella
    [J]. PHARMACOLOGICAL REVIEWS, 2021, 73 (01) : 202 - 277
  • [22] Efficacy of psychedelics in psychiatry, a systematic review of the literature
    Berkovitch, L.
    Romeo, B.
    Karila, L.
    Gaillard, R.
    Benyamina, A.
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2021, 47 (04): : 376 - 387
  • [23] Psychedelics and ketamine are a symptom of psychiatry's woes, not a cure
    Miller, Andrew H.
    Raison, Charles L.
    [J]. MOLECULAR PSYCHIATRY, 2023, 28 (08) : 3167 - 3168
  • [24] Can psychedelics have a role in psychiatry once again?
    Sessa, B
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2005, 186 : 457 - 458
  • [25] Psychedelics and ketamine are a symptom of psychiatry’s woes, not a cure
    Andrew H. Miller
    Charles L. Raison
    [J]. Molecular Psychiatry, 2023, 28 : 3167 - 3168
  • [26] Psychedelics in Psychiatry, the Nursing Influence, and the Future of Psychedelic Therapies
    Spotswood, Carlton J.
    [J]. JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION, 2024, 30 (05) : 906 - 913
  • [27] Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets
    Sousa, Teresa Reynolds
    Rema, Joao
    Machado, Sergio
    Novais, Filipa
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2022, 22 (15) : 1250 - 1260
  • [28] Classical psychedelics in psychiatry-renaissance of interest and therapeutic perspectives
    Jachimowski, Askaniusz
    Kucia, Krzysztof
    [J]. PSYCHIATRIA POLSKA, 2023, 57 (03) : 657 - 670
  • [29] From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders
    Kozlowska, Urszula
    Nichols, Charles
    Wiatr, Kalina
    Figiel, Maciej
    [J]. JOURNAL OF NEUROCHEMISTRY, 2022, 162 (01) : 89 - 108
  • [30] Skip the Trip? Five Arguments on the Use of Nonhallucinogenic Psychedelics in Psychiatry
    Peterson, Andrew
    Sisti, Dominic
    [J]. CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS, 2022, 31 (04) : 472 - 476